Catalent (NYSE: CTLT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Catalent (NYSE: CTLT) through any online brokerage.
The latest price target for Catalent (NYSE: CTLT) was reported by Morgan Stanley on Wednesday, May 4, 2022. The analyst firm set a price target for 132.00 expecting CTLT to rise to within 12 months (a possible 19.39% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Catalent (NYSE: CTLT) is $110.56 last updated August 5, 2022, 7:59 PM UTC.
There are no upcoming dividends for Catalent.
Catalent’s Q1 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Catalent.
Catalent is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.